WO2017067089A1 - Neovison vison klebsiella peneumoniae - Google Patents

Neovison vison klebsiella peneumoniae Download PDF

Info

Publication number
WO2017067089A1
WO2017067089A1 PCT/CN2016/000100 CN2016000100W WO2017067089A1 WO 2017067089 A1 WO2017067089 A1 WO 2017067089A1 CN 2016000100 W CN2016000100 W CN 2016000100W WO 2017067089 A1 WO2017067089 A1 WO 2017067089A1
Authority
WO
WIPO (PCT)
Prior art keywords
strain
klebsiella pneumoniae
cfu
klebsiella
pneumoniae
Prior art date
Application number
PCT/CN2016/000100
Other languages
French (fr)
Chinese (zh)
Inventor
王贵升
王金宝
田夫林
单虎
Original Assignee
王贵升
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 王贵升 filed Critical 王贵升
Publication of WO2017067089A1 publication Critical patent/WO2017067089A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/22Klebsiella

Definitions

  • the invention relates to a strain of Klebsiella pneumoniae, belonging to the technical field of microorganisms.
  • Klebsiella pneumoniae (Klebsiella peneumoniae) belongs to the family Enterobacteriaceae, Klebsiella, Gram-negative (G -). Facultative anaerobic, no flagella and spores, with obvious capsules, most strains have pili. Klebsiella pneumoniae has K (capsular) antigen and O (bacteria) antigen, the former being lipopolysaccharide and the latter being polysaccharide. K antigen can be used for the identification of bacterial types.
  • Klebsiella pneumoniae can be divided into 82 K serotypes, wherein the K1, K2 and K5 serotypes are closely related to severe infectious diseases in humans and animals.
  • the strain was first isolated from the lung tissue of patients with lobar pneumonia in 1883. It is a common pathogen of hospital-acquired pneumonia (HAP). In recent years, in human infection, the strain is in addition to E. coli.
  • iatrogenic infection is pathogenic bacteria, which can cause infection in multiple parts of the body, but the highest incidence in the urinary tract and respiratory tract, when the body's immunity is reduced or due to long-term use of antibiotics, the body Infection caused by flora imbalance can lead to pneumonia, meningitis, liver abscess, endophthalmitis, urinary tract inflammation, wound infection and systemic sepsis, which brings great difficulties to clinical treatment, and the morbidity and mortality are extremely high.
  • animal infections various livestock, poultry, wild animals and aquatic animals can be infected. Broilers and laying hens in poultry are susceptible to infection. Pigs, cattle, sheep and rabbits can be infected in livestock, in addition to wild and aquatic animals.
  • the giant panda, golden monkey, Chinese sturgeon, etc. can also be infected, among which the white mice and the chickens within 15 days old are most susceptible to the bacteria.
  • animal infection with klebsiella which can cause liver necrosis in chickens, pneumonia in rabbits, enteritis, diarrhea in giant pandas, hepatitis, diarrhea in pigs, death of cattle and sheep, etc.
  • causes a large number of deaths such as fur otters, moles, and bamboo rats.
  • Due to the abuse of antibiotics the drug resistance of the bacteria is increasing, and the emergence of multi-drug resistant strains brings great difficulties to clinical treatment.
  • Klebsiella pneumoniae is not only more harmful to livestock and poultry, but also causes the incidence of fur animals (fox, scorpion, leeches) to rise, leading to pneumonia, metritis, mastitis and other diseases in fur animals. Suppurative inflammation. In foreign countries, Morris first reported rickettsial disease in the United States in 1947. It is characterized by posterior numbness and sepsis of abscess cellulitis. In China, Zhao Chunde et al first reported two ⁇ in Zhoushan City in 1987. Klebsiella pneumoniae occurred in the field, with acute abscess in the neck as the main feature, and the mortality rate was higher.
  • mice The median lethal dose to mice was 1.53 ⁇ 10 8 CFU/mL; the half lethal doses of two strains of K. pneumoniae KP-ZC1 and KP-ZC2 isolated from leeches were 4.9 ⁇ 10 6 CFU/mL, respectively. , 3.1 ⁇ 10 6 CFU / mL; Li Fuxiang and other isolated KP14013 strain on the mice lethal dose of 3 ⁇ 10 1.8 CFU.
  • the invention separates Klebsiella from the Klebsiella sinensis disease material, and isolates and purifies and cultures to obtain a highly toxic Klebsiella; polymerase chain reaction (PCR), transmission Electron microscopy and nucleic acid sequence analysis methods were used to identify and confirm the isolates of Klebsiella pneumoniae; it provided a basis for further research and control of Klebsiella pneumoniae.
  • PCR polymerase chain reaction
  • a strain of Klebsiella pneumoniae named WMOK strain, accession number: CGMCC NO.11222.
  • the WMOK strain of K. pneumoniae of the present invention is K2 type, Gram stain is negative (G-), facultative anaerobic, no flagella and spore, and has obvious capsule, and most strains have pili. Both ends are obtusely rounded.
  • the drug resistance of the K. pneumoniae WMOK strain of the present invention is as follows:
  • Sensitive piperacillin, cefotetan, ertapenem, imipenem, amikacin, levofloxacin, nitrofurantin.
  • the diseased sputum (mainly characterized by lack of energy, weight loss, etc.) was cultured on a urinary tract chromogenic medium at 37 ° C for 12 hours; a single blue-gray colony was picked (Klebsiella pneumoniae) The bacteria were grown as blue-gray colonies on the urinary tract chromogenic medium, and they were streaked on tryptone soy agar medium to purify the colonies.
  • the purified colonies were subjected to PCR amplification, and the amplified products were sequenced.
  • the results of sequencing the PCR reaction products were Blast, and compared with the published gene sequence of K. pneumoniae in GenBank, homology. It reaches 99%-100%.
  • the K. pneumoniae WMOK strain of the present invention has an LD 50 of 2.1 ⁇ 10 0.5 CFU for KM mice.
  • the virulence is significantly stronger than other Klebsiella strains that have been reported so far.
  • the present invention measures the LD 50 of Klebsiella pneumoniae on leech for the first time, and the WMOK strain of K. pneumoniae of the present invention has an LD 50 of 3.8 ⁇ 10 0.7 CFU for leech.
  • the K. pneumoniae WMOK strain of the present invention is highly toxic and can be used as an attacking strain for the development of a subsequent product.
  • FIG. 1 Electropherogram of PCR amplification products of Klebsiella pneumoniae: M. pneumoniae DNA standard DL 2 000; 1-6. PCR product designated as K. pneumoniae WMOK strain colony; 7 positive control (take K. pneumoniae ATCC 700603 purchased from the US Standard Biological Collection Center as a control); 8. Negative control (take E. coli ATCC 25922 purchased from the American Standard Biological Collection Center as a negative control);
  • Fig. 2 is a photograph of the K. pneumoniae WMOK strain of the present invention observed under an electron microscope.
  • the diseased material came from a large-scale mink farm in Shandong province. Before the death of the disease, the main manifestations were lack of energy, difficulty in breathing and so on. SPF Kunming mice were purchased from Shandong Experimental Animal Center.
  • the tryptone soy agar medium, the tryptone soy broth medium and the urinary tract group chromogenic medium are all commonly used in the field; the components of the tryptone soy agar medium are tryptone, soybean meal, sodium chloride, The agar; tryptone soy broth medium components are tryptone, soy peptone, sodium chloride, dipotassium hydrogen phosphate, glucose; urinary flora group chromogenic medium components are agar, peptone, yeast powder, pigment.
  • a single blue-gray colony (Klebsiella pneumoniae was grown as a blue-gray colony on the urinary tract chromogenic medium) was picked and streaked on tryptone soy agar medium to purify the colonies. If the bacterial colonies are still impure after a pure culture, continue to pick a single colony for bacterial bacteria. Purify until pure colonies grow.
  • the Klebsiella pneumoniae colonies purified in operation 1 were subjected to PCR amplification using the above primers, and the PCR products obtained by PCR amplification were sequenced to Shandong Academy of Agricultural Sciences, and the results of sequencing the PCR reaction products were subjected to Blast. Compared to the published gene sequences in GenBank, the homology is 99%-100%.
  • the gene sequence of the amplified product is shown in SEQ ID NO. 5, SEQ ID NO.
  • the obtained K. pneumoniae WMOK strain was washed with tryptone soy broth medium for 14 hours, and the conditions were as follows: centrifugation at 3000 rpm for 10 min, the supernatant was discarded, and the slime was resuspended in physiological saline. After repeated washing 5 times, The morphology of the bacteria was observed by transmission electron microscopy. The bacteria observed under the transmission electron microscope were rod-shaped at both ends, as shown in Fig. 2.
  • strains stored in glycerol were taken out from the refrigerator, naturally thawed at room temperature, and a loop of bacteria was aseptically picked and streaked onto tryptone soy agar medium, and cultured at 37 ° C for 16-18 h to carry out strain recovery. .
  • a single colony of the resuscitation on tryptone soy agar medium was inoculated into a triangular flask containing 100 mL of tryptone soy broth medium, and placed in a constant temperature shaker at 180 r/min and 37 ° C for 12 hours to prepare a seed liquid.
  • the prepared seed solution was inoculated into 200 mL of tryptone soy broth medium at a seeding ratio of 1% by volume, and placed in a constant temperature oscillator at 180 r/min and 37 ° C for 14 hours.
  • the Maid turbidity measurement and the viable count were performed.
  • mice Sixty SPF KM mice weighing approximately 20 g, half male and half female, were randomly divided into 6 groups, ten in each group. Each group was injected with different dilutions of bacterial liquid (in the case of undiluted original bacterial solution, 2.1 ⁇ 10 9 CFU/mL), 0.2 mL/only, and the control group was injected with the same amount of physiological saline for 7 days.
  • Table 1 The results are shown in Table 1:
  • the mortality rate was 100% in the 10 -5 , 10 -6 , 10 -7 and 10 -8 dilution groups , and 30 % in the 10 -9 dilution group .
  • the median lethal dose was 2.1 ⁇ 10 0.5 CFU measured by the ⁇ method . That is, intraperitoneal injection of mice at a dose of 2.1 ⁇ 10 0.5 CFU / 0.2 mL can cause 50% of mice to die.
  • the mortality rate was 100% in the 10 -5 , 10 -6 , 10 -7 dilution group , 80 % in the 10 -8 dilution group , and 0 in the 10 -9 dilution group .
  • the median lethal dose measured by the method of ⁇ is 3.8 ⁇ 10 0.7 CFU, that is, intraperitoneal injection of leeches at a dose of 3.8 ⁇ 10 0.7 CFU/mL can cause 50% of leeches to die.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Provided is a neovison vison klebsiella peneumoniae strain which is named as a WMOK strain with the preservation number of CGMCC NO.11222. The strain is K2 type, is Gram-negative (G-), facultatively anaerobic, atrichous and asporous, and has an obvious capsule; most strains have fimbriae and are rod-shaped with finely rounded terminuses. The WMOK strain has relatively high toxicity, and has a half lethal dose of 2.1×100.5 CFU to mice and a half lethal dose of 3.8×100.7 CFU to neovison vison.

Description

一株水貂肺炎克雷伯氏菌Klebsiella pneumoniae 技术领域Technical field
本发明涉及一株水貂肺炎克雷伯氏菌,属于微生物技术领域。The invention relates to a strain of Klebsiella pneumoniae, belonging to the technical field of microorganisms.
背景技术Background technique
肺炎克雷伯氏菌(Klebsiella peneumoniae)属于肠杆菌科,克雷伯菌属,革兰氏染色为阴性(G-)。兼性厌氧,无鞭毛和芽孢,有明显的荚膜,多数菌株有菌毛。肺炎克雷伯氏菌有K(荚膜)抗原与O(菌体)抗原,前者为脂多糖类,后者为多糖类。K抗原可用于菌型的鉴定。根据荚膜多糖(K抗原)分型,可将肺炎克雷伯氏菌分为82个K血清型,其中K1,K2和K5血清型是与人和动物体的严重感染性疾病密切相关的。该菌于1883年Friediander从患大叶性肺炎病人的肺组织中首次分离得到,该菌是医院获得性肺炎(HAP)的常见致病菌,近年来在人类感染中该菌是除大肠杆菌外的医源性感染最重要条件致病菌,该菌可引起全身多个部位发生感染,但在尿路和呼吸道的发病率最高,当机体的免疫力降低或者由于长期大量的使用抗生素而导致机体菌群失调时而引起感染,可导致肺炎、脑膜炎、肝脓肿、眼内炎、泌尿系统发炎、伤口感染和全身败血症等,给临床治疗带来了很大困难,发病率和死亡率极高。在动物感染中各种家畜、家禽、野生动物及水生动物都可感染,家禽中肉鸡和蛋鸡都易感染,家畜中猪、牛、羊和獭兔均可感染该病,此外野生及水生动物中的大熊猫、金丝猴、中华鳌等也可感染,其中以小白鼠和15日龄以内小鸡对本菌最易感。近几年来动物感染克雷伯氏菌病的报道不断增多,该菌可以导致雏鸡肝脏坏死,家兔的肺炎、肠炎,大熊猫的腹泻、肝炎,猪的腹泻以及牛、羊死亡等,并可引起毛皮动物水貂、麝鼠、竹鼠等大量死亡。由于抗生素类药物的滥用,导致该菌的耐药性不断增强,多重耐药菌株的出现,给临床治疗带来极大困难。Klebsiella pneumoniae (Klebsiella peneumoniae) belongs to the family Enterobacteriaceae, Klebsiella, Gram-negative (G -). Facultative anaerobic, no flagella and spores, with obvious capsules, most strains have pili. Klebsiella pneumoniae has K (capsular) antigen and O (bacteria) antigen, the former being lipopolysaccharide and the latter being polysaccharide. K antigen can be used for the identification of bacterial types. According to the capsular polysaccharide (K antigen) typing, Klebsiella pneumoniae can be divided into 82 K serotypes, wherein the K1, K2 and K5 serotypes are closely related to severe infectious diseases in humans and animals. The strain was first isolated from the lung tissue of patients with lobar pneumonia in 1883. It is a common pathogen of hospital-acquired pneumonia (HAP). In recent years, in human infection, the strain is in addition to E. coli. The most important condition of iatrogenic infection is pathogenic bacteria, which can cause infection in multiple parts of the body, but the highest incidence in the urinary tract and respiratory tract, when the body's immunity is reduced or due to long-term use of antibiotics, the body Infection caused by flora imbalance can lead to pneumonia, meningitis, liver abscess, endophthalmitis, urinary tract inflammation, wound infection and systemic sepsis, which brings great difficulties to clinical treatment, and the morbidity and mortality are extremely high. In animal infections, various livestock, poultry, wild animals and aquatic animals can be infected. Broilers and laying hens in poultry are susceptible to infection. Pigs, cattle, sheep and rabbits can be infected in livestock, in addition to wild and aquatic animals. The giant panda, golden monkey, Chinese sturgeon, etc. can also be infected, among which the white mice and the chickens within 15 days old are most susceptible to the bacteria. In recent years, there have been reports of animal infection with klebsiella, which can cause liver necrosis in chickens, pneumonia in rabbits, enteritis, diarrhea in giant pandas, hepatitis, diarrhea in pigs, death of cattle and sheep, etc. Caused a large number of deaths such as fur otters, moles, and bamboo rats. Due to the abuse of antibiotics, the drug resistance of the bacteria is increasing, and the emergence of multi-drug resistant strains brings great difficulties to clinical treatment.
肺炎克雷伯氏菌不仅对畜禽的危害越来越严重,而且引起毛皮动物(狐狸、貉子、水貂)的发病率也呈上升趋势,导致毛皮动物的肺炎、子宫炎、乳腺炎及其它化脓性炎症。在国外,1947年Morris在美国首次报道了貂克雷伯氏菌病,以脓肿蜂窝织炎后躯麻痹和脓毒败血症为特征,在国内,赵纯德等在1987年首次报道了舟山市两个貂场发生肺炎克雷伯氏菌,以颈部急性脓肿为主要特征,病死率较高。此后国内外陆续出现肺炎克雷伯氏菌引起毛皮动物发病的报道。国内目前已有学者报道过肺炎克雷伯氏菌在小鼠上的半数致死量,马磊等从竹鼠中分离的克雷伯氏菌对小白鼠的半数致死量为4.5×107CFU/只;张诗渝等测定了分离株KPm0912与标准株KP1300的半数致死量,分别为1.1×105CFU/mL和1.3× 106CFU/mL;钟世勋等从毛皮动物分离的肺炎克雷伯氏菌K1对小鼠的半数致死量为1.53×108CFU/mL;王剑等从水貂中分离的两株克雷伯氏菌KP-ZC1和KP-ZC2半数致死量分别为4.9×106CFU/mL、3.1×106CFU/mL;李富祥等分离的KP14013株对小白鼠半数致死量为3×101.8CFU。Klebsiella pneumoniae is not only more harmful to livestock and poultry, but also causes the incidence of fur animals (fox, scorpion, leeches) to rise, leading to pneumonia, metritis, mastitis and other diseases in fur animals. Suppurative inflammation. In foreign countries, Morris first reported rickettsial disease in the United States in 1947. It is characterized by posterior numbness and sepsis of abscess cellulitis. In China, Zhao Chunde et al first reported two 貂 in Zhoushan City in 1987. Klebsiella pneumoniae occurred in the field, with acute abscess in the neck as the main feature, and the mortality rate was higher. Since then, there have been reports of the incidence of fur animals caused by Klebsiella pneumoniae at home and abroad. At present, scholars in China have reported the median lethal dose of Klebsiella pneumoniae in mice. The median lethal dose of Klebsiella isolated from bamboo rats to horses is 4.5×10 7 CFU/ Only; Zhang Shizhen et al. determined the median lethal dose of the isolate KPm0912 and the standard strain KP1300, which were 1.1×10 5 CFU/mL and 1.3×10 6 CFU/mL, respectively; and the Klebsiella pneumoniae K1 isolated from fur animals such as Zhong Shixun et al. The median lethal dose to mice was 1.53×10 8 CFU/mL; the half lethal doses of two strains of K. pneumoniae KP-ZC1 and KP-ZC2 isolated from leeches were 4.9×10 6 CFU/mL, respectively. , 3.1 × 10 6 CFU / mL; Li Fuxiang and other isolated KP14013 strain on the mice lethal dose of 3 × 10 1.8 CFU.
发明内容Summary of the invention
本发明从水貂克雷伯氏菌病病料中分离克雷伯氏菌,经划线分离、纯化培养得到一株毒性优异的克雷伯氏菌;经聚合酶链式反应(PCR)、透射电镜及核酸序列分析等方法鉴定、证实分离株为肺炎克雷伯氏菌;为下一步深入开展肺炎克雷伯氏菌的相关研究及控制提供了一定的基础。The invention separates Klebsiella from the Klebsiella sinensis disease material, and isolates and purifies and cultures to obtain a highly toxic Klebsiella; polymerase chain reaction (PCR), transmission Electron microscopy and nucleic acid sequence analysis methods were used to identify and confirm the isolates of Klebsiella pneumoniae; it provided a basis for further research and control of Klebsiella pneumoniae.
技术方案Technical solutions
一株水貂肺炎克雷伯氏菌,命名为WMOK株,保藏号:CGMCC NO.11222。A strain of Klebsiella pneumoniae, named WMOK strain, accession number: CGMCC NO.11222.
本发明的水貂肺炎克雷伯氏菌WMOK株为K2型,革兰氏染色为阴性(G-),兼性厌氧,无鞭毛和芽孢,有明显的荚膜,多数菌株有菌毛,呈两端钝圆的杆状。The WMOK strain of K. pneumoniae of the present invention is K2 type, Gram stain is negative (G-), facultative anaerobic, no flagella and spore, and has obvious capsule, and most strains have pili. Both ends are obtusely rounded.
本发明的水貂肺炎克雷伯氏菌WMOK株,其耐药性情况为:The drug resistance of the K. pneumoniae WMOK strain of the present invention is as follows:
耐药:氨苄西林、氨苄青霉素、头孢唑林、头孢他啶、头孢曲松、头孢吡肟、安曲南、庆大霉素、复方新诺明;Resistance: ampicillin, ampicillin, cefazolin, ceftazidime, ceftriaxone, cefepime, antrexam, gentamicin, cotrimoxazole;
中敏:妥布霉素、环丙沙星;Zhongmin: tobramycin, ciprofloxacin;
敏感:哌拉西林、头孢替坦、厄他培南、亚胺培南、阿米卡星、左氧氟沙星、呋喃妥英。Sensitive: piperacillin, cefotetan, ertapenem, imipenem, amikacin, levofloxacin, nitrofurantin.
本发明的水貂肺炎克雷伯氏菌的获取方法:Method for obtaining Klebsiella pneumoniae of the present invention:
将病死水貂(死亡前主要表现为精神不振、消瘦呼吸困难等)肝脏内部组织在尿路菌群显色培养基上于37℃恒温培养12小时;挑取单个蓝灰色菌落(肺炎克雷伯氏菌在尿路菌群显色培养基上生长为蓝灰色菌落)将其在胰蛋白胨大豆琼脂培养基上划线分离,进行菌落的纯化。The diseased sputum (mainly characterized by lack of energy, weight loss, etc.) was cultured on a urinary tract chromogenic medium at 37 ° C for 12 hours; a single blue-gray colony was picked (Klebsiella pneumoniae) The bacteria were grown as blue-gray colonies on the urinary tract chromogenic medium, and they were streaked on tryptone soy agar medium to purify the colonies.
对纯化好菌落进行PCR扩增,对扩增产物进行序列测定,PCR反应产物测序后的结果进行Blast,与GenBank中的已发表的水貂肺炎克雷伯氏菌的基因序列相对比,同源性达到99%-100%。The purified colonies were subjected to PCR amplification, and the amplified products were sequenced. The results of sequencing the PCR reaction products were Blast, and compared with the published gene sequence of K. pneumoniae in GenBank, homology. It reaches 99%-100%.
本发明的水貂肺炎克雷伯氏菌WMOK株,对KM小鼠的LD50为2.1×100.5CFU。毒力明显强于目前已报道的其它克雷伯氏菌菌株。The K. pneumoniae WMOK strain of the present invention has an LD 50 of 2.1 × 10 0.5 CFU for KM mice. The virulence is significantly stronger than other Klebsiella strains that have been reported so far.
本发明首次测定了肺炎克雷伯氏菌在水貂上的LD50,本发明的水貂肺炎克雷伯氏菌 WMOK株,对水貂的LD50为3.8×100.7CFU。The present invention measures the LD 50 of Klebsiella pneumoniae on leech for the first time, and the WMOK strain of K. pneumoniae of the present invention has an LD 50 of 3.8 × 10 0.7 CFU for leech.
有益效果Beneficial effect
本发明的水貂肺炎克雷伯氏菌WMOK株毒性很强,可作为后续产品研发时的攻毒用菌株。The K. pneumoniae WMOK strain of the present invention is highly toxic and can be used as an attacking strain for the development of a subsequent product.
保藏信息Deposit information
保藏时间:2015年8月11日Deposit time: August 11, 2015
保藏单位名称:中国微生物菌种保藏管理委员会普通微生物中心Name of the depository: General Microbiology Center of China Microbial Culture Collection Management Committee
保藏编号:CGMCC NO.11222Deposit number: CGMCC NO.11222
保藏单位地址:北京市朝阳区北辰西路1号院3号 中国科学院微生物研究所Depository Address: No. 3, No.1, Beichen West Road, Chaoyang District, Beijing, China Institute of Microbiology, Chinese Academy of Sciences
分类命名:肺炎克雷伯氏菌(Klebsiella peneumoniae)Classification: Klebsiella peneumoniae
附图说明DRAWINGS
图1,肺炎克雷伯氏菌PCR扩增产物的电泳图:M水貂肺炎克雷伯氏菌DNA标准DL 2 000;1-6.命名为肺炎克雷伯氏菌WMOK株菌落的PCR产物;7阳性对照(以购买于美国标准生物品收藏中心的肺炎克雷伯氏菌ATCC 700603作为对照);8.阴性对照(以购买于美国标准生物品收藏中心的大肠杆菌ATCC 25922作为阴性对照);Figure 1. Electropherogram of PCR amplification products of Klebsiella pneumoniae: M. pneumoniae DNA standard DL 2 000; 1-6. PCR product designated as K. pneumoniae WMOK strain colony; 7 positive control (take K. pneumoniae ATCC 700603 purchased from the US Standard Biological Collection Center as a control); 8. Negative control (take E. coli ATCC 25922 purchased from the American Standard Biological Collection Center as a negative control);
图2,电镜下观察到的本发明的肺炎克雷伯氏菌WMOK株的照片。Fig. 2 is a photograph of the K. pneumoniae WMOK strain of the present invention observed under an electron microscope.
具体实施方式detailed description
下述实施例中,病料来自山东某规模化水貂养殖场,病貂死亡前主要表现为精神不振、消瘦呼吸困难等。SPF级昆明小鼠购自山东省实验动物中心。胰蛋白胨大豆琼脂培养基、胰蛋白胨大豆肉汤培养基和尿路菌群显色培养基均为本领域常用培养基;胰蛋白胨大豆琼脂培养基的成分为胰蛋白胨、大豆胨、氯化钠、琼脂;胰蛋白胨大豆肉汤培养基的成分为胰蛋白胨、大豆蛋白胨、氯化钠、磷酸氢二钾、葡萄糖;尿路菌群显色培养基的成分为琼脂、蛋白胨、酵母粉、色素。In the following examples, the diseased material came from a large-scale mink farm in Shandong Province. Before the death of the disease, the main manifestations were lack of energy, difficulty in breathing and so on. SPF Kunming mice were purchased from Shandong Experimental Animal Center. The tryptone soy agar medium, the tryptone soy broth medium and the urinary tract group chromogenic medium are all commonly used in the field; the components of the tryptone soy agar medium are tryptone, soybean meal, sodium chloride, The agar; tryptone soy broth medium components are tryptone, soy peptone, sodium chloride, dipotassium hydrogen phosphate, glucose; urinary flora group chromogenic medium components are agar, peptone, yeast powder, pigment.
实施例1Example 1
1.细菌分离与纯化1. Bacterial isolation and purification
用手术刀无菌操作,打开病死水貂的胸腔、腹腔,使主要器官暴露出来。用剪刀做“井”字型剪开病死水貂的肝脏,充分暴露其内部组织;用无菌的一次性棉签蘸取肝脏内部后分别在尿路菌群显色培养基上做“之”字划线,将划上细菌的培养皿做好标记后放入生化培养箱中,37℃恒温培养12个小时后观察细菌生长情况。挑取单个蓝灰色菌落(肺炎克雷伯氏菌在尿路菌群显色培养基上生长为蓝灰色菌落),并将其在胰蛋白胨大豆琼脂培养基上划线分离,进行菌落的纯化。若一次纯培养后细菌菌落仍旧不纯,继续挑取单个菌落进行细菌的菌 落纯化,直到长出纯菌落为止。Sterile operation with a scalpel, open the chest and abdomen of the sick sputum, expose the main organs. Use the scissors to make the "well" shape to cut the liver of the diseased sputum, fully expose the internal tissues; use a sterile disposable cotton swab to take the inside of the liver and make a "Zi" on the urinary tract chromogenic medium. Line, the bacteria dish marked with bacteria was marked and placed in a biochemical incubator. After incubating at 37 ° C for 12 hours, the growth of the bacteria was observed. A single blue-gray colony (Klebsiella pneumoniae was grown as a blue-gray colony on the urinary tract chromogenic medium) was picked and streaked on tryptone soy agar medium to purify the colonies. If the bacterial colonies are still impure after a pure culture, continue to pick a single colony for bacterial bacteria. Purify until pure colonies grow.
2.PCR鉴定2. PCR identification
引物:根据GenBank发表的肺炎克雷伯氏菌的特异性基因Khe,采用Primer软件设计出两对引物,由上海生工生物技术服务有限公司合成。引物序列分别为:Primers: According to the specific gene Khe of K. pneumoniae published by GenBank, two pairs of primers were designed by Primer software and synthesized by Shanghai Shenggong Biotechnology Service Co., Ltd. The primer sequences are:
Figure PCTCN2016000100-appb-000001
如SEQ ID NO.1所示;
Figure PCTCN2016000100-appb-000001
As shown in SEQ ID NO.
Figure PCTCN2016000100-appb-000002
如SEQ ID NO.2所示;
Figure PCTCN2016000100-appb-000002
As shown in SEQ ID NO. 2;
Figure PCTCN2016000100-appb-000003
如SEQ ID NO.3所示;
Figure PCTCN2016000100-appb-000003
As shown in SEQ ID NO. 3;
Figure PCTCN2016000100-appb-000004
如SEQ ID NO.4所示。
Figure PCTCN2016000100-appb-000004
As shown in SEQ ID NO.
操作1中纯化好的肺炎克雷伯氏菌菌落,分别使用上述引物进行PCR扩增,将PCR扩增得到的PCR产物往山东省农业科学院进行序列测定,PCR反应产物测序后的结果进行Blast,与GenBank中的已发表的基因序列相对比,同源性达到99%-100%。扩增产物的基因序列如SEQ ID NO.5、SEQ ID NO.6所示。The Klebsiella pneumoniae colonies purified in operation 1 were subjected to PCR amplification using the above primers, and the PCR products obtained by PCR amplification were sequenced to Shandong Academy of Agricultural Sciences, and the results of sequencing the PCR reaction products were subjected to Blast. Compared to the published gene sequences in GenBank, the homology is 99%-100%. The gene sequence of the amplified product is shown in SEQ ID NO. 5, SEQ ID NO.
引物对K1扩增的基因序列:Primer pair K1 amplified gene sequence:
Figure PCTCN2016000100-appb-000005
Figure PCTCN2016000100-appb-000005
引物对K2扩增的基因序列:Primer pair K2 amplified gene sequence:
Figure PCTCN2016000100-appb-000006
Figure PCTCN2016000100-appb-000006
3.电镜观察3. Electron microscopic observation
将获得的貂肺炎克雷伯氏菌WMOK株用胰蛋白胨大豆肉汤培养基培养14h的菌液进行洗涤,条件为:3000rpm离心10min,弃去上清,将菌泥用生理盐水重悬。重复洗涤5次后, 透射电镜观察细菌形态。透射电子显微镜下观察到的细菌呈两端钝圆的杆状,见图2。The obtained K. pneumoniae WMOK strain was washed with tryptone soy broth medium for 14 hours, and the conditions were as follows: centrifugation at 3000 rpm for 10 min, the supernatant was discarded, and the slime was resuspended in physiological saline. After repeated washing 5 times, The morphology of the bacteria was observed by transmission electron microscopy. The bacteria observed under the transmission electron microscope were rod-shaped at both ends, as shown in Fig. 2.
4.细菌LD50测定4. Determination of bacterial LD50
①菌种复苏1 strain recovery
将保存于甘油中的菌种从冰箱中取出,放于室温自然解冻,无菌挑取一环菌液划线接种于胰蛋白胨大豆琼脂培养基上,37℃培养16-18h,进行菌种复苏。The strains stored in glycerol were taken out from the refrigerator, naturally thawed at room temperature, and a loop of bacteria was aseptically picked and streaked onto tryptone soy agar medium, and cultured at 37 ° C for 16-18 h to carry out strain recovery. .
②种子液制备2 seed liquid preparation
挑取复苏在胰蛋白胨大豆琼脂培养基上的单个菌落接种于装有100mL胰蛋白胨大豆肉汤培养基的三角瓶,置恒温振荡器中,180r/min、37℃培养12h,制备种子液。A single colony of the resuscitation on tryptone soy agar medium was inoculated into a triangular flask containing 100 mL of tryptone soy broth medium, and placed in a constant temperature shaker at 180 r/min and 37 ° C for 12 hours to prepare a seed liquid.
③扩大培养3 expansion training
将制备的种子液按1%(体积比)的接种比例接种于200mL胰蛋白胨大豆肉汤培养基中,置恒温振荡器,180r/min、37℃培养14h。进行麦氏浊度测定以及活菌计数。The prepared seed solution was inoculated into 200 mL of tryptone soy broth medium at a seeding ratio of 1% by volume, and placed in a constant temperature oscillator at 180 r/min and 37 ° C for 14 hours. The Maid turbidity measurement and the viable count were performed.
④细菌在小鼠上的LD50 4 bacteria LD 50 in mice
60只体重20g左右的SPF级KM小鼠,雌雄各半,随机分成6组,每组十只。各组分别注射不同稀释度的菌液(未稀释的原始菌液的情况为2.1×109CFU/mL),0.2mL/只,对照组注射等量生理盐水,连续观察7天。结果如表1所示:Sixty SPF KM mice weighing approximately 20 g, half male and half female, were randomly divided into 6 groups, ten in each group. Each group was injected with different dilutions of bacterial liquid (in the case of undiluted original bacterial solution, 2.1×10 9 CFU/mL), 0.2 mL/only, and the control group was injected with the same amount of physiological saline for 7 days. The results are shown in Table 1:
表1Table 1
稀释度Dilution 10-5 10 -5 10-6 10 -6 10-7 10 -7 10-8 10 -8 10-9 10 -9
死亡率 mortality rate 100%100% 100%100% 100%100% 100%100% 30%30%
10-5,10-6,10-7和10-8稀释组死亡率为100%,10-9稀释组死亡率为30%;用寇氏法测得其半数致死量为2.1×100.5CFU,即按2.1×100.5CFU/0.2mL的剂量腹腔注射小鼠,可引起50%的小鼠死亡。The mortality rate was 100% in the 10 -5 , 10 -6 , 10 -7 and 10 -8 dilution groups , and 30 % in the 10 -9 dilution group . The median lethal dose was 2.1 × 10 0.5 CFU measured by the 寇 method . That is, intraperitoneal injection of mice at a dose of 2.1 × 10 0.5 CFU / 0.2 mL can cause 50% of mice to die.
⑤细菌在水貂上的LD50 5 LD 50 of bacteria on leech
30只4月龄健康易感水貂,随机分成6组,每组5只。各组分别注射不同稀释度的菌液(未稀释的原始菌液的情况为3.8×109CFU/mL),1.0mL/只,对照组注射等量生理盐水,连续观察14天。结果如图表2所示:Thirty healthy, susceptible leeches of 4 months old were randomly divided into 6 groups of 5 animals each. Each group was injected with different dilutions of bacterial solution (in the case of undiluted original bacterial solution, 3.8×10 9 CFU/mL), 1.0 mL/only, and the control group was injected with the same amount of physiological saline for 14 days. The result is shown in Figure 2:
表2Table 2
稀释度Dilution 10-5 10 -5 10-6 10 -6 10-7 10 -7 10-8 10 -8 10-9 10 -9
死亡率 mortality rate 100%100% 100%100% 100%100% 80%80% 00
结果10-5,10-6,10-7稀释组死亡率为100%,10-8稀释组死亡率为80%,10-9稀释组死亡率为0。用寇氏法测得其半数致死量为3.8×100.7CFU,即按3.8×100.7CFU/mL的剂量腹腔注射水貂,可引起50%的水貂死亡。 Results The mortality rate was 100% in the 10 -5 , 10 -6 , 10 -7 dilution group , 80 % in the 10 -8 dilution group , and 0 in the 10 -9 dilution group . The median lethal dose measured by the method of 寇 is 3.8×10 0.7 CFU, that is, intraperitoneal injection of leeches at a dose of 3.8×10 0.7 CFU/mL can cause 50% of leeches to die.

Claims (5)

  1. 一株水貂肺炎克雷伯氏菌,命名为WMOK株,保藏号:CGMCC NO.11222。A strain of Klebsiella pneumoniae, named WMOK strain, accession number: CGMCC NO.11222.
  2. 根据权利要求1所述的水貂肺炎克雷伯氏菌,其特征在于,为K2型,革兰氏染色为阴性,兼性厌氧,无鞭毛和芽孢,有明显的荚膜,多数菌株有菌毛,呈两端钝圆的杆状。The Klebsiella pneumoniae according to claim 1, characterized in that it is K2 type, Gram stain is negative, facultative anaerobic, flagellar and spore-free, with obvious capsule, and most strains have bacteria The hair is in the shape of a rod that is obtuse at both ends.
  3. 根据权利要求1或2所述的水貂肺炎克雷伯氏菌,其特征在于,其耐药性情况为:The Klebsiella pneumoniae strain according to claim 1 or 2, wherein the drug resistance is as follows:
    耐药:氨苄西林、氨苄青霉素、头孢唑林、头孢他啶、头孢曲松、头孢吡肟、安曲南、庆大霉素、复方新诺明;Resistance: ampicillin, ampicillin, cefazolin, ceftazidime, ceftriaxone, cefepime, antrexam, gentamicin, cotrimoxazole;
    中敏:妥布霉素、环丙沙星;Zhongmin: tobramycin, ciprofloxacin;
    敏感:哌拉西林、头孢替坦、厄他培南、亚胺培南、阿米卡星、左氧氟沙星、呋喃妥英。Sensitive: piperacillin, cefotetan, ertapenem, imipenem, amikacin, levofloxacin, nitrofurantin.
  4. 根据权利要求3所述的水貂肺炎克雷伯氏菌,其特征在于,对KM小鼠的LD50为2.1×100.5CFU。The Klebsiella pneumoniae strain according to claim 3, wherein the LD 50 for KM mice is 2.1 × 10 0.5 CFU.
  5. 根据权利要求3所述的水貂肺炎克雷伯氏菌,其特征在于,对水貂的LD50为3.8×100.7CFU。 The Klebsiella pneumoniae strain according to claim 3, wherein the LD 50 for leech is 3.8 × 10 0.7 CFU.
PCT/CN2016/000100 2015-10-19 2016-02-26 Neovison vison klebsiella peneumoniae WO2017067089A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510680802.6A CN105199991A (en) 2015-10-19 2015-10-19 Neovison vison klebsiella peneumoniae
CN201510680802.6 2015-10-19

Publications (1)

Publication Number Publication Date
WO2017067089A1 true WO2017067089A1 (en) 2017-04-27

Family

ID=54947954

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/000100 WO2017067089A1 (en) 2015-10-19 2016-02-26 Neovison vison klebsiella peneumoniae

Country Status (2)

Country Link
CN (1) CN105199991A (en)
WO (1) WO2017067089A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113621722A (en) * 2021-08-17 2021-11-09 汉唐和元(武汉)科技有限公司 Porcine Klebsiella pneumoniae detection kit and application thereof
CN113881589A (en) * 2021-09-09 2022-01-04 山东省农业科学院畜牧兽医研究所 Klebsiella pneumoniae KP21 strain and application thereof
CN115895937A (en) * 2022-08-23 2023-04-04 华南农业大学 Klebsiella pneumoniae obtained through microgravity mutagenesis breeding and culture method and application thereof
CN116098993A (en) * 2022-11-17 2023-05-12 中国农业科学院特产研究所 Triple inactivated vaccine for fox and raccoon dog pneumonia and preparation method thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105199991A (en) * 2015-10-19 2015-12-30 王贵升 Neovison vison klebsiella peneumoniae
CN107365869B (en) * 2017-09-08 2021-03-19 江苏农林职业技术学院 Method and primer for detecting Klebsiella pneumoniae by loop-mediated isothermal amplification technology
CN110241060B (en) 2019-08-02 2020-10-09 青岛农业大学 Mink klebsiella pneumoniae and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105199991A (en) * 2015-10-19 2015-12-30 王贵升 Neovison vison klebsiella peneumoniae

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105199991A (en) * 2015-10-19 2015-12-30 王贵升 Neovison vison klebsiella peneumoniae

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HU , BENGANG ET AL.: "Isolation and Identification of Klebsiella pneumoniae from Mink", CHINESE JOURNAL OF PREVENTIVE VETERINARY MEDICINE, vol. 33, no. 8, 31 August 2011 (2011-08-31), ISSN: 1008-0589 *
JI, HONGLI ET AL.: "Serotype Distribution of Clinical Isolates of Klebsiella pneumoniae", CHINESE JOURNAL OF INFECTION AND CHEMOTHERAPY, vol. 11, no. 3, 31 May 2011 (2011-05-31), ISSN: 1009-7708 *
MA, RONG ET AL.: "Distribution and Antibiotic Resistance of Klebsiella pneumoniae Strains in Terms of K1 and K2 Serotypes", CHINESE JOURNAL OF INFECTION AND CHEMOTHERAPY, vol. 15, no. 3, 31 May 2015 (2015-05-31), ISSN: 1009-7708 *
SHEN, DINGXIA ET AL.: "Detection of Capsular Serotype and Virulence Gene of Klebsiella pneumonia with Hypermucoviscosity Phenotype", CHINESE JOURNAL OF LABORATORY MEDICINE, vol. 37, no. 5, 31 May 2014 (2014-05-31), ISSN: 1009-9158 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113621722A (en) * 2021-08-17 2021-11-09 汉唐和元(武汉)科技有限公司 Porcine Klebsiella pneumoniae detection kit and application thereof
CN113881589A (en) * 2021-09-09 2022-01-04 山东省农业科学院畜牧兽医研究所 Klebsiella pneumoniae KP21 strain and application thereof
CN115895937A (en) * 2022-08-23 2023-04-04 华南农业大学 Klebsiella pneumoniae obtained through microgravity mutagenesis breeding and culture method and application thereof
CN115895937B (en) * 2022-08-23 2024-05-10 华南农业大学 Klebsiella pneumoniae bred by microgravity mutagenesis and culture method and application thereof
CN116098993A (en) * 2022-11-17 2023-05-12 中国农业科学院特产研究所 Triple inactivated vaccine for fox and raccoon dog pneumonia and preparation method thereof

Also Published As

Publication number Publication date
CN105199991A (en) 2015-12-30

Similar Documents

Publication Publication Date Title
WO2017067089A1 (en) Neovison vison klebsiella peneumoniae
CN112029732B (en) High-temperature-resistant salmonella bacteriophage with wide lysis spectrum and composition thereof
CN108699531B (en) Pasteurella multocida bacteriophage Pas-MUP-1 and application thereof in inhibiting proliferation of Pasteurella multocida
WO2017020784A1 (en) Bacteroides fragilis and application thereof
US10265356B2 (en) Enteroinvasive E. coli bacteriophage Esc-COP-4 and use thereof for inhibiting proliferation of enteroinvasive E. coli
US9956256B2 (en) Bacteriophage and composition comprising same
CN113583972A (en) Escherichia coli bacteriophage capable of reducing antibiotic resistance and application thereof
US4892731A (en) Biological intestinal antiseptics
CN113416712A (en) Wide lysis spectrum salmonella bacteriophage and application thereof
CN108018230B (en) Serum 7 type haemophilus parasuis natural attenuated strain and application thereof
CN112143709A (en) Aeromonas hydrophila phage and application thereof
CN108179136B (en) Escherichia coli bacteriophage Esc-COP-9 and pathogenic escherichia coli proliferation inhibition application thereof
CN108103029B (en) Bacteriophage capable of cleaving bovine streptococcus agalactiae and application thereof
WO2023207887A1 (en) Bacillus subtilis zf-1 and use thereof in inhibiting african swine fever virus
CN106795498B (en) Bacteriophage, compositions comprising same, and uses thereof
CN115704002B (en) Clostridium butyricum CC02001 and application thereof
US20190321423A1 (en) Escherichia coli bacteriophage esc-cop-9 and use for inhibiting proliferation of pathogenic escherichia coli thereof
NL2022691B1 (en) A Strain of Klebsiella pneumoniae Isolated From Mink
CN111518716B (en) Lactobacillus plantarum and application thereof
CN113018426B (en) Combined strain for preparing haemophilus parasuis vaccine, octavalent inactivated vaccine and application thereof
CN113018425B (en) Mycoplasma hyopneumoniae and haemophilus parasuis bivalent pentavalent inactivated vaccine and application thereof
CN112831442B (en) Serum 14 type haemophilus parasuis with cross protection and application thereof
CN118006561B (en) High-cracking-rate campylobacter jejuni bacteriophage RDP-CJ-22002, and bactericidal composition and application thereof
CN117327628B (en) Lactobacillus gasseri Mia capable of fermenting Chinese herbal medicine and resisting HPV virus and application thereof
TWI810805B (en) Lactic acid bacteria complex composition and its use in preparation of oral composition of inhibiting drug-resistant enterobacteriaceae

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16856537

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 17.08.2018)

122 Ep: pct application non-entry in european phase

Ref document number: 16856537

Country of ref document: EP

Kind code of ref document: A1